Trial Profile
PTH [parathyroid hormone] & Ibandronate [ibandronic acid, Boniva] Combination Study (PICS): Optimizing the Use of PTH With Boniva [ibandronic acid] (Pilot Randomized Controlled Trial)
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Ibandronic acid (Primary) ; Parathyroid hormone (Primary)
- Indications Bone resorption; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms PICS
- 12 Jul 2012 Results published in the Journal of Clinical Endocrinology and Metabolism.
- 20 Sep 2011 Results presented at the 33rd Annual Meeting of the American Society for Bone and Mineral Research.
- 27 May 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.